Tetratricopeptide Repeat Domain 9: A Potential Drug Target (G23508)

Target Name: TTC9

NCBI ID: G23508

TTC9

Tetratricopeptide Repeat Domain 9: A Potential Drug Target

Tetratricopeptide repeat domain 9 (TTC9) is a protein that is found in various organisms, including humans. It is characterized by the repeated sequence of the amino acid leucine in the protein sequence. This repeated sequence is known as a \"tetratricopeptide repeat\" and is a hallmark of the protein.

TTC9 is involved in a number of different cellular processes in the body, including cell signaling, DNA replication, and metabolism. It is also involved in the development and maintenance of tissues, such as muscle and bone.

One of the key functions of TTC9 is its role in cell signaling. TTC9 is a negative regulator of the protein kinase kinase (PKG), which is involved in a number of different cellular processes, including cell signaling and metabolism. PKG is an enzyme that is activated by the phosphorylation of a specific site on the protein, and TTC9 is thought to act as an inhibitor to prevent PKG from being activated.

Another function of TTC9 is its role in DNA replication. TTC9 is involved in the regulation of DNA replication in various organisms, including humans. It is known to be involved in the formation of a protein complex that is necessary for the proper functioning of DNA replication.

In addition to its role in cell signaling and DNA replication, TTC9 is also involved in the development and maintenance of tissues. TTC9 is known to be involved in the regulation of cell proliferation and cell differentiation, as well as the formation of tissues such as muscle and bone.

TTC9 is also of interest as a potential drug target. Its role in cell signaling, DNA replication, and tissue development make it a potential target for small molecules that can modulate these processes. For example, drugs that inhibit PKG activity or that interfere with the The formation of tissues by TTC9 could potentially be used to treat a variety of diseases, such as cancer, diabetes, and muscle and bone diseases.

In conclusion, Tetratricopeptide repeat domain 9 (TTC9) is a protein that is involved in a number of different cellular processes in the body, including cell signaling, DNA replication, and tissue development. Its role in these processes makes it a potential drug target, and its properties as a negative regulator of the protein kinase (PKG) make it an attractive target for small molecules that can modulate these processes. Further research is needed to fully understand the role of TTC9 in the body and its potential as a drug.

Protein Name: Tetratricopeptide Repeat Domain 9

The "TTC9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TTC9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets